ReachRxResearch
Home
Research
Sign Up
  1. Home
  2. Research Hub
  3. USH2A-Associated Retinitis Pigmentosa in…

USH2A-Associated Retinitis Pigmentosa in Koreans: Molecular Genetics and Clinical Characteristics

American Journal of Ophthalmology·September 3
OphthalmologyPractice changingRetinitis PigmentosaUsher SyndromeRetrospective Cohort StudyGene Therapy / Exon-Targeted TherapyAdult

Summary

View source

What was studied

Retrospective cohort study of 182 Korean patients with biallelic pathogenic USH2A variants, evaluating the molecular genetic spectrum and age-related clinical features (BCVA, Goldmann visual field, EZ band length) of USH2A-associated retinitis pigmentosa, stratified by Usher syndrome vs. non-syndromic RP and by truncating variant burden.

Key findings

The most common allele was c.2802T>G (p.Cys934Trp) at 23.6% of 364 alleles; 45.1% of patients carried at least one copy. European hotspots c.2299delG and c.2276G>T were absent. Usher syndrome (30.8%) and higher truncating variant burden both correlated with worse visual acuity, visual field, and ellipsoid zone band length.

Study limitations

Retrospective single-population design limits generalizability to other East Asian or non-Asian groups. Cross-sectional age-modeling with splines is an imperfect substitute for longitudinal follow-up. Referral-based cohort may over-represent more severely affected patients.

Clinical implications

Korean RP patients should be screened for c.2802T>G rather than European USH2A hotspots. Because ~45% of this cohort carry at least one exon 13 c.2802T>G allele, East Asian patients are strong candidates for emerging exon 13-targeted therapies.

Caveats

  • Mean age of 44.3 years suggests predominantly adult patients, but the age range is not explicitly stated — some younger patients may be included.
  • The c.2802T>G variant falls in exon 13 of USH2A; the paper supports exon 13-targeted therapy eligibility but does not report efficacy data for any specific therapy.
  • The impact_flag 'practice_changing' reflects the variant screening guidance for East Asian populations; formal clinical practice guidelines have not yet been updated based on this single study.

Related Questions

Explore related topics

What exon 13-targeted therapies are in development for USH2A-associated retinitis pigmentosa?How does the USH2A variant spectrum differ between East Asian and European patients with retinitis pigmentosa?What clinical features distinguish Usher syndrome from non-syndromic retinitis pigmentosa in USH2A patients?

Publication Details

Year
2026
Journal
American Journal of Ophthalmology
Sample Size
n=182
Source
View article
Keep scrolling
More content below.
Up Next